Chinese government confirms GSK bribery probe
This article was originally published in Scrip
Executive Summary
China's Ministry of Public Security has issued a statement providing official confirmation that an investigation of some executives at GlaxoSmithKline's operations in the country is underway, on suspicion of their involvement in what it terms "serious economic crimes".